A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies

Deregulated mRNA transcription and protein translation in the transformation of normal T-cells to malignant cells.

Functional analysis of the RNA helicase DHX15 in T-cell acutelymphoblastic leukemia

5-hydroxy-methyl-cytosine (5hmC) distribution in T-cell acute lymphoblastic leukemia (T-ALL)

beurs Emmaunuel van der Schueren voor Tim Pieters: MYB and the role of super-enhancers in T-ALL

BOF-ZAP professorship in normal and malignant hematopoiesis

Combination of targeted therapy and chemotherapy in acute lymphoblastic leukemia

Combination therapies with the LSD1 inhibitor GSK2879552 for the treatment of T-cell acute lymphoblastic leukemia

Dynamic Interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation

ETV6 : the Achilles' heel of early T-cell progenitor T-cell acute lymphoblastic leukemia

Functional heterogeneity in T-cell acute lymphoblastic leukemia

Functional heterogeneity in T-cell acute lymphoblastic leukemia

Interplay between microRNAs and oncogenic networks in T-cell acute lymphoblastic leukemia (miRtalL)

Minimal residual disease targeting in T-cell acute lymphoblastic leukemia

Molecular mechanisms controlling pre-leukemic stem cells in the thymus

Novel mouse models of mantle cell lymphoma for preclinical testing of anti-leukemic drugs

Novel therapeutic agents for the treatment of early T-cell progenitor leukemia

Oncogenic activation and therapeutic targeting of PIM1 in T-cell acute lymphoblastic lymphoma

Oncogenic activation and therapeutic targeting of PIM1 in T-cell acute lymphoblastic lymphoma

Oncogenic activation and therapeutic targeting of PIM1 in T-cell acute lymphoblastic lymphoma

On the road to excellence in unravelling the (epi)genetic landscape of hematologic neoplasms

Preclinical evaluation of withaferin A chemosensitation in GC therapy resistant B-and T-cll heaematological malignancies

Preclinical validation of a less toxic variant for paediatric leukemia

Proteogenomics in T-cell acute lymphoblastic leukemia

Purchase of equipment as part of a scientific research on childhood cancer

Role of TET2 in (pre)-leukemic T-ALL: TET2 to the rescue

Swiss Bridge Award: Understanding sensitivity towards LSD1 inhibition in T-cell Acute Lymphoblastic Leukemia

Targeted immunotherapy for the treatment of T-cell acute lymphoblastic leukemia

Targeting aberrant DNA methylation in T-cell acute lymphoblastic leukemia (T-ALL) and lymphoma (T-LBL)

Targeting IL4 signaling as a novel therapeutic strategy in the treatment of T-cell acute lymphoblastic leukemia

Targeting oncogenic PIM1 kinase activation in T-cell acute lymphoblastic leukemia and lymphoma

Targeting the leukemic cancer stam cell in early T-cell precursor Acute Lymphoblastic Leukemia (ETP-ALL)

Targetting the chromatin for innovative cancer therapy

The dual role PSIP1 in T-cell acute lymphoblastic leukemia (T-ALL)

Therapeutic targeting of oncogenic MYB activity in T-ALL

The role of BRWD2/PHIP as a novel epigenetic tumor suppressor in T-cell acute lymphoblastic leukemia and lymphoma

The role of SOX11 in T-ALL

The role of SOX11 in T-cell acute lymphoblastic leukemia

The role of TET2 in (pre)-leukemic T-cell acute lymphoblastic leukemia

Unravelling cellular heterogeneity and dynamics in normal and malignant hematopoiesis using singlecell bioinformatics

An alternative more tolerable L-asparaginase variant for the treatment of metastatic breast cancer

Characterizing and targeting aberrant splicing activity in acute leukemia

Dynamic interplay between DNA mehtylation, histone modifications and the activity of super enhancers in the pathogenesis of immature T-ALL

ETV6: the Achilles’ heel of early T-cell progenitor T-cell acute lymphoblastic leukemia.

High throughput MS-based histone PTM screening: Filling a void in pharmacoepigenetics.

IVIS Lumina III LT In Vivo imaging system.

Natural functional plasticizers for controlled protein folding and extrustion into biomaterials

Purchase and installation of a bedding dump system for the SPF animalarium MRB2

RUNX2 as a driver of poor prognostic early T-cell progenitor leukemia

RUNX2 as a driver of poor prognostic early T-cell progenitor leukemia

Screening for drivers and dependency factors in a novel genetic model for T-ALL in Xenopus tropicalis

SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomics

Targeting the leukemic cancer stem cell in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL)

The BD FACS Symphony FACS cell sorter: the most advanced multiparameter fluorescence activated cell sorter that allows the identification and purification of rare cells for further functional characterization

BOF-ZAP professorship in normal and malignant hematopoiesis

Novel mouse models of mantle cell lymphoma for preclinical testing of anti-leukemic drugs

The use of a less toxic alternative asparaginase variant to treat metastatic breast cancer